Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis

Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dose reduction or discontinuation of disease‐modifying anti‐rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a commo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2022-01, Vol.2022 (1)
Hauptverfasser: Renton, William D, Tiller, Georgina, Munro, Jane, Tan, Joachim, Johnston, Renea V, Avery, Jodie C, Whittle, Samuel L, Arno, Anneliese, Buchbinder, Rachelle
Format: Artikel
Sprache:eng
Schlagworte:
Pediatric Rheumatology [juvenile rheumatoid]
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title Cochrane database of systematic reviews
container_volume 2022
creator Renton, William D
Tiller, Georgina
Munro, Jane
Tan, Joachim
Johnston, Renea V
Avery, Jodie C
Whittle, Samuel L
Arno, Anneliese
Buchbinder, Rachelle
description This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dose reduction or discontinuation of disease‐modifying anti‐rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non‐systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.
doi_str_mv 10.1002/14651858.CD014961
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8747987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8747987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2581-798e7866de2b0d2c921dd69beafe336b2c3bdf012b55b5c165727a6318b11cb83</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMoOKd_gG951IfOJF3T9EUY6_yAiSD6HPLVNWNNRtJO9t_bOif6dC-_e-45cAC4xmiCESJ3eEozzDI2mZcITwuKT8BoYMkAT__s5-AixjVCKS1IPgKfpY8GBqM71VrvoHAaahuVd611nfhmvhqQEdEkjde22lu36oWtTUJtuqYXKahDt4rwpnyZvZXxFlY-wHW3M85uDLTa-q1o614mQlsH29p4Cc4qsYnm6meOwcfD4n3-lCxfH5_ns2WiSMZwkhfM5IxSbYhEmqiCYK1pIY2oTJpSSVQqdYUwkVkmM4VplpNc0BQzibGSLB2D-4PvtpON0cq4NogN3wbbiLDnXlj-_-JszVd-x1k-7cPz3gAfDFTwMQZT_f5ixIfq-bF6fqw-_QJT0Hqe</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis</title><source>Cochrane Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Renton, William D ; Tiller, Georgina ; Munro, Jane ; Tan, Joachim ; Johnston, Renea V ; Avery, Jodie C ; Whittle, Samuel L ; Arno, Anneliese ; Buchbinder, Rachelle</creator><creatorcontrib>Renton, William D ; Tiller, Georgina ; Munro, Jane ; Tan, Joachim ; Johnston, Renea V ; Avery, Jodie C ; Whittle, Samuel L ; Arno, Anneliese ; Buchbinder, Rachelle</creatorcontrib><description>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dose reduction or discontinuation of disease‐modifying anti‐rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non‐systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.</description><identifier>ISSN: 1465-1858</identifier><identifier>EISSN: 1465-1858</identifier><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD014961</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Pediatric Rheumatology [juvenile rheumatoid]</subject><ispartof>Cochrane database of systematic reviews, 2022-01, Vol.2022 (1)</ispartof><rights>Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2581-798e7866de2b0d2c921dd69beafe336b2c3bdf012b55b5c165727a6318b11cb83</citedby><cites>FETCH-LOGICAL-c2581-798e7866de2b0d2c921dd69beafe336b2c3bdf012b55b5c165727a6318b11cb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Renton, William D</creatorcontrib><creatorcontrib>Tiller, Georgina</creatorcontrib><creatorcontrib>Munro, Jane</creatorcontrib><creatorcontrib>Tan, Joachim</creatorcontrib><creatorcontrib>Johnston, Renea V</creatorcontrib><creatorcontrib>Avery, Jodie C</creatorcontrib><creatorcontrib>Whittle, Samuel L</creatorcontrib><creatorcontrib>Arno, Anneliese</creatorcontrib><creatorcontrib>Buchbinder, Rachelle</creatorcontrib><title>Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis</title><title>Cochrane database of systematic reviews</title><description>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dose reduction or discontinuation of disease‐modifying anti‐rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non‐systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.</description><subject>Pediatric Rheumatology [juvenile rheumatoid]</subject><issn>1465-1858</issn><issn>1465-1858</issn><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkN1LwzAUxYMoOKd_gG951IfOJF3T9EUY6_yAiSD6HPLVNWNNRtJO9t_bOif6dC-_e-45cAC4xmiCESJ3eEozzDI2mZcITwuKT8BoYMkAT__s5-AixjVCKS1IPgKfpY8GBqM71VrvoHAaahuVd611nfhmvhqQEdEkjde22lu36oWtTUJtuqYXKahDt4rwpnyZvZXxFlY-wHW3M85uDLTa-q1o614mQlsH29p4Cc4qsYnm6meOwcfD4n3-lCxfH5_ns2WiSMZwkhfM5IxSbYhEmqiCYK1pIY2oTJpSSVQqdYUwkVkmM4VplpNc0BQzibGSLB2D-4PvtpON0cq4NogN3wbbiLDnXlj-_-JszVd-x1k-7cPz3gAfDFTwMQZT_f5ixIfq-bF6fqw-_QJT0Hqe</recordid><startdate>20220111</startdate><enddate>20220111</enddate><creator>Renton, William D</creator><creator>Tiller, Georgina</creator><creator>Munro, Jane</creator><creator>Tan, Joachim</creator><creator>Johnston, Renea V</creator><creator>Avery, Jodie C</creator><creator>Whittle, Samuel L</creator><creator>Arno, Anneliese</creator><creator>Buchbinder, Rachelle</creator><general>John Wiley &amp; Sons, Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20220111</creationdate><title>Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis</title><author>Renton, William D ; Tiller, Georgina ; Munro, Jane ; Tan, Joachim ; Johnston, Renea V ; Avery, Jodie C ; Whittle, Samuel L ; Arno, Anneliese ; Buchbinder, Rachelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2581-798e7866de2b0d2c921dd69beafe336b2c3bdf012b55b5c165727a6318b11cb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Pediatric Rheumatology [juvenile rheumatoid]</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Renton, William D</creatorcontrib><creatorcontrib>Tiller, Georgina</creatorcontrib><creatorcontrib>Munro, Jane</creatorcontrib><creatorcontrib>Tan, Joachim</creatorcontrib><creatorcontrib>Johnston, Renea V</creatorcontrib><creatorcontrib>Avery, Jodie C</creatorcontrib><creatorcontrib>Whittle, Samuel L</creatorcontrib><creatorcontrib>Arno, Anneliese</creatorcontrib><creatorcontrib>Buchbinder, Rachelle</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Renton, William D</au><au>Tiller, Georgina</au><au>Munro, Jane</au><au>Tan, Joachim</au><au>Johnston, Renea V</au><au>Avery, Jodie C</au><au>Whittle, Samuel L</au><au>Arno, Anneliese</au><au>Buchbinder, Rachelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis</atitle><jtitle>Cochrane database of systematic reviews</jtitle><date>2022-01-11</date><risdate>2022</risdate><volume>2022</volume><issue>1</issue><issn>1465-1858</issn><eissn>1465-1858</eissn><eissn>1469-493X</eissn><abstract>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dose reduction or discontinuation of disease‐modifying anti‐rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non‐systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><doi>10.1002/14651858.CD014961</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-1858
ispartof Cochrane database of systematic reviews, 2022-01, Vol.2022 (1)
issn 1465-1858
1465-1858
1469-493X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8747987
source Cochrane Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Pediatric Rheumatology [juvenile rheumatoid]
title Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A05%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dose%20reduction%20and%20discontinuation%20of%20disease-modifying%20anti-rheumatic%20drugs%20(DMARDs)%20for%20juvenile%20idiopathic%20arthritis&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Renton,%20William%20D&rft.date=2022-01-11&rft.volume=2022&rft.issue=1&rft.issn=1465-1858&rft.eissn=1465-1858&rft_id=info:doi/10.1002/14651858.CD014961&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8747987%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true